人卵巢局部合成皮质类固醇的新证据
该观察性研究纳入34例卵巢冷冻保存女性和50例IVF/ICSI女性,检测卵泡液和血浆类固醇浓度及颗粒细胞酶表达。发现卵泡液中皮质醇前体显著富集(FF/血浆比>10),提示卵巢具备局部合成皮质类固醇的能力,且皮质醇活性在排卵前后受动态调控。
要点
- 卵泡液中11-脱氧皮质醇和11-脱氧皮质酮显著高于血浆(FF/血浆比>10),提示局部合成。
- 卵泡内皮质醇随卵泡增大先升后降,排卵前急剧升高(从<40至约100 nM)。
- 颗粒细胞表达CYP21A2和低水平CYP11B1,且CYP21A2定位于腔前和小窦卵泡。
核心结论
- 人卵巢具备部分合成皮质类固醇的能力,利用局部丰富的前体物质。
- 皮质醇生物活性通过灭活和再激活机制在排卵期受时间调控,以支持炎症消退。
研究设计与样本
- 观察性研究,纳入34例卵巢冷冻保存女性和50例IVF/ICSI女性。
- 检测卵泡液和血浆类固醇(LC-MS/MS)、颗粒细胞酶mRNA(RT-qPCR)及CYP21A2免疫荧光定位。
主要发现
- 卵泡内皮质醇随卵泡大小增至8-10 mm后下降,排卵前急剧升高(从<40至约100 nM)。
- 皮质酮仅在排卵时 detectable,醛固酮未检出。
- 卵泡液皮质醇浓度持续低于血浆(FF/血浆比<0.1),HSD11B2高表达提示灭活。
临床怎么用
- 局部皮质醇动态可能影响排卵过程和黄体形成,其失调或与黄体期不足相关。
局限性
- 因抗体限制未能定位CYP11B1蛋白。
- 卵泡液和血浆来自不同个体,无法直接配对比较。
- 血浆采集时间存在日间变异,限制昼夜波动结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does the human ovary possess the enzymatic machinery required for local corticosteroid synthesis during follicular development? SUMMARY ANSWER: The human ovary exhibits dynamic corticosteroid metabolism during follicular development and expresses enzymes consistent with local corticosteroid synthesis. WHAT IS KNOWN ALREADY: Cortisol is a systemic glucocorticoid that binds to the glucocorticoid receptor (NR3C1), which is expressed in ovarian tissues. While excess systemic cortisol impairs follicular development, a surge in local cortisol activity around ovulation appears necessary for limiting the impact of the inflammatory process taking place. The preovulatory upregulation of 11β-hydroxysteroid dehydrogenase type 1 (HSD11B1) suggests local conversion of cortisone to active cortisol. However, whether the ovary can synthesize corticosteroids de novo remains uncertain. STUDY DESIGN, SIZE, DURATION: This observational study included samples from 34 women undergoing ovarian cryopreservation and samples from 50 women undergoing IVF/ICSI according to a standard antagonist protocol at a university hospital-affiliated fertility clinic in Denmark. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women donated follicular fluid (FF), plasma, and granulosa cells. Steroid concentrations in FF and plasma were quantified using LC-MS/MS. Granulosa cell mRNA expression of steroidogenic enzymes (CYP11B1, CYP11B2, CYP21A2, HSD11B1, HSD11B2) was assessed by RT-qPCR. In addition, immunofluorescence (IF) was used to localize CYP21A2 in preantral and small antral follicles. FF samples were stratified according to follicle size (2-18 mm) and ovulatory status. Hormone dynamics and FF/plasma ratio were evaluated using linear mixed-effects models and non-parametric tests. MAIN RESULTS AND THE ROLE OF CHANCE: Intrafollicular cortisol levels increased with follicle size up to 8-10 mm, then declined until close to ovulation, where a sharp increase was observed (from <40 to ∼100 nM). In contrast, cortisone showed an inverse pattern, remaining elevated throughout the follicular phase but dropping sharply at ovulation. The cortisol/cortisone ratio shifted markedly at the time corresponding to ovulation. Cortisol precursors, particularly 11-deoxycortisol and 11-deoxycorticosterone, were substantially enriched in FF compared to plasma (FF/plasma ratios >10), suggesting local synthesis. This is supported by the expression of CYP21A2 and low-level CYP11B1 mRNA in GCs, and by IF localization of CYP21A2 in preantral and small antral follicles. In contrast, FF cortisol concentrations were consistently lower than in plasma (FF/plasma ratio <0.1), indicating active inactivation by HSD11B2, which was abundantly expressed. HSD11B1 expression was low but detectable in periovulatory follicles, consistent with local reactivation of cortisone to cortisol. Among mineralocorticoids, corticosterone was only detectable at ovulation, while aldosterone was undetectable. LIMITATIONS, REASONS FOR CAUTION: We were unable to localize CYP11B1 at the protein level due to limitations in available antibodies. Additionally, FF and plasma samples were obtained from different individuals, precluding direct paired comparisons. Some variability in plasma sample collection timing throughout the day also limits conclusions regarding diurnal fluctuations. WIDER IMPLICATIONS OF THE FINDINGS: These findings suggest that the human ovary possesses the capacity for partial corticosteroid synthesis, utilizing locally abundant precursors. Cortisol bioactivity appears to be temporally regulated through both inactivation and reactivation mechanisms, enabling a controlled, pro-resolving inflammatory response at ovulation. This mechanism may be essential for timely corpus luteum formation and maintenance of luteal phase integrity. Dysregulation of local cortisol dynamics may contribute to luteal phase insufficiency in a subset of women. The concept of a follicular "inflammatome" and its role in ovulatory success warrants further exploration. FUNDING: This research was supported by the University Hospital of Copenhagen (Rigshospitalet), The University of Copenhagen, and Novo Nordisk Foundation grant number NNF21OC00700556, as well as founded by the Interreg ÔKS V through ReproUnion (www.reprounion.eu) and a grant from Region Zealand Research Foundation. The funders had no role in study design, collection of data, analyses, writing of the manuscript, or the decision to submit it for publication. DISCLOSURES: During the preparation of this work, the author(s) used ChatGPT 4o for language assistance. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article. Furthermore, CYA has received consultant fees and honoraria for lectures from Ferring and IBSA. TRIAL REGISTRATION NUMBER: N/A.
引用
- Johannsen ML, Styrishave B, Zheng M, et al. Evidence for de novo synthesis of corticosteroids in the human ovary. Hum Reprod. 2026. PMID: 42402373. doi:10.1093/humrep/deag107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。